1. Home
  2. LWAY vs CMPX Comparison

LWAY vs CMPX Comparison

Compare LWAY & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$30.78

Market Cap

474.0M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.08

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWAY
CMPX
Founded
1986
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.0M
408.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
LWAY
CMPX
Price
$30.78
$2.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$34.50
$14.57
AVG Volume (30 Days)
181.0K
2.6M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
48.33
N/A
EPS
0.30
N/A
Revenue
$103,350,000.00
N/A
Revenue This Year
$16.64
N/A
Revenue Next Year
$17.28
$934.41
P/E Ratio
$101.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.31
$1.61
52 Week High
$34.20
$6.88

Technical Indicators

Market Signals
Indicator
LWAY
CMPX
Relative Strength Index (RSI) 57.65 44.68
Support Level $22.03 $1.88
Resistance Level $31.23 $2.14
Average True Range (ATR) 1.35 0.11
MACD -0.29 -0.01
Stochastic Oscillator 58.21 25.68

Price Performance

Historical Comparison
LWAY
CMPX

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: